You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 9,186,332


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,186,332 protect, and when does it expire?

Patent 9,186,332 protects RAYOS and is included in one NDA.

This patent has twenty-three patent family members in nineteen countries.

Summary for Patent: 9,186,332
Title:Delayed release tablet with defined core geometry
Abstract: A tablet comprising a core containing an active agent, and a coating, the core being disposed within the coating such that the coating has a thickness about a longitudinal axis (X-Y) of about 4.85 to 4.95 mm. The position of the core within the coating dictating that the active agent is released rapidly after a lag time during which time no active agent is released.
Inventor(s): Vergnault; Guy (Kembs, FR), Grenier; Pascal (Kappelen, FR), Dragan; Christophe (Geispitzen, FR)
Assignee: Jagotec AG (Muttenz, CH)
Application Number:13/713,528
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for United States Patent 9,186,332

Introduction

United States Patent 9,186,332, hereafter referred to as the '332 patent, is a patent that has been granted by the U.S. Patent and Trademark Office (USPTO). To understand the scope, claims, and the patent landscape surrounding this patent, it is crucial to delve into several key aspects.

Patent Overview

The '332 patent typically includes a detailed description of the invention, the background of the invention, a summary of the invention, and the detailed description of the preferred embodiments. This information is crucial for understanding what the patent covers and what it does not.

Claims Analysis

Independent and Dependent Claims

The claims section of the patent is the most critical part as it defines the scope of the invention. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details. Analyzing these claims helps in understanding the exact boundaries of what is patented.

Claim Construction

Claim construction involves interpreting the language of the claims to determine their scope. This process is often a point of contention in patent litigation and requires careful analysis of the claim language, the specification, and any relevant prosecution history[5].

Scope of the Invention

Invention Description

The '332 patent describes the invention in detail, including its components, how it works, and its intended use. This description helps in understanding the scope of the invention and how it differs from prior art.

Background and Summary

The background section provides context about the existing technology and the problems it addresses, while the summary section gives a concise overview of the invention. These sections are essential for grasping the broader context in which the patent exists.

Patent Landscape Analysis

Competitor Patents

A patent landscape analysis involves identifying and analyzing patents held by competitors in the same technology area. This helps in understanding the competitive landscape, identifying gaps in the market, and making strategic decisions about R&D and IP management[3].

Prior Art and Saturation

Analyzing prior art and the level of patent saturation in the technology area can reveal whether the '332 patent is part of a highly saturated field or if it occupies a niche space. This information is crucial for determining the patent's value and potential for future innovation[3].

Global Dossier and International Filings

Using tools like the Global Dossier provided by the USPTO, one can access the file histories of related applications from participating IP Offices. This helps in understanding the global reach and filings related to the '332 patent, including any international counterparts or family members[4].

Inventorship and Ownership

True and Only Inventors

Correctly determining the inventors of the '332 patent is vital. US patent law requires that only the true and only inventors be listed on the patent application. Errors in inventorship can lead to the patent being invalid or unenforceable[5].

Patent Assignment and Ownership

The ownership of the '332 patent can change over time through assignments or other transactions. The USPTO provides tools for searching patent assignments, which is essential for understanding the current ownership and any changes in ownership history[4].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of Patent Term Adjustment (PTA) or other reasons. This is particularly relevant if the '332 patent is part of a family of patents with varying expiration dates[1].

Patent Term and Expiration

Understanding the patent term and expiration date is critical. The '332 patent's term would typically be 20 years from the filing date of the earliest non-provisional application to which it claims priority, unless extended by PTA or other mechanisms. Any terminal disclaimers or PTA grants can affect the expiration date[1].

Litigation and Enforcement

The '332 patent's enforceability can be affected by various factors, including the accuracy of inventorship, the validity of the claims, and any prior litigation or reexamination proceedings. Ensuring that the patent is valid and enforceable is crucial for its value and the ability to protect the invention[5].

Strategic Insights and Decision-Making

A comprehensive patent landscape analysis can provide strategic insights that help in making long-term decisions about R&D, IP management, and market strategy. This includes identifying areas of high patent saturation, potential competitors, and opportunities for innovation[3].

Key Takeaways

  • Claims and Scope: The claims define the scope of the invention, and understanding them is crucial for determining what is patented.
  • Patent Landscape: Analyzing the competitive landscape helps in identifying gaps, competitors, and strategic opportunities.
  • Inventorship and Ownership: Correct inventorship and clear ownership are essential for the patent's validity and enforceability.
  • ODP and Patent Term: Understanding ODP and patent term adjustments is vital for managing the patent's expiration and validity.
  • Strategic Decisions: A comprehensive analysis informs long-term decisions about R&D, IP management, and market strategy.

Frequently Asked Questions (FAQs)

What is the significance of claim construction in patent analysis?

Claim construction is crucial as it determines the scope of the invention and is often a point of contention in patent litigation.

How does patent landscape analysis benefit business and R&D management?

Patent landscape analysis helps in identifying competitors, gaps in the market, and opportunities for innovation, enabling strategic decisions about R&D and IP management.

What are the consequences of incorrect inventorship in a patent application?

Incorrect inventorship can lead to the patent being invalid or unenforceable, especially if there is deceptive intent involved.

How does the Global Dossier help in patent analysis?

The Global Dossier provides access to the file histories of related applications from participating IP Offices, helping in understanding the global reach and filings related to a patent.

What is the impact of ODP on patent validity and expiration?

ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent filed at the same time but with a different patent term, affecting the patent's validity and expiration.

Cited Sources:

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Landscape Analysis - Uncovering Strategic Insights
  4. Search for patents - USPTO
  5. Determining Inventorship for US Patent Applications

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,186,332

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Horizon RAYOS prednisone TABLET, DELAYED RELEASE;ORAL 202020-001 Jul 26, 2012 DISCN Yes No 9,186,332 ⤷  Subscribe TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET ⤷  Subscribe
Horizon RAYOS prednisone TABLET, DELAYED RELEASE;ORAL 202020-002 Jul 26, 2012 DISCN Yes No 9,186,332 ⤷  Subscribe TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET ⤷  Subscribe
Horizon RAYOS prednisone TABLET, DELAYED RELEASE;ORAL 202020-003 Jul 26, 2012 DISCN Yes No 9,186,332 ⤷  Subscribe TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,186,332

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0309342.4Apr 24, 2003

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.